Total Debt
$73.3M
Net Debt
-$321.4M
Theravance Biopharma Inc currently has $73.3M in total debt. Net debt is -$321.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
TBPH • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.07 | 0.39 | -0.32Net Cash | 0.47 | 15.5% |
| 2025-12-31 | 0.08 | 0.32 | -0.24Net Cash | 0.49 | 15.5% |
| 2025-09-30 | 0.04 | 0.33 | -0.29Net Cash | 0.42 | 10.7% |
| 2025-06-30 | 0.05 | 0.34 | -0.29Net Cash | 0.43 | 10.9% |
| 2025-03-31 | 0.05 | 0.13 | -0.08Net Cash | 0.34 | 14.0% |
| 2024-12-31 | 0.05 | 0.09 | -0.04Net Cash | 0.35 | 14.1% |
| 2024-09-30 | 0.04 | 0.09 | -0.05Net Cash | 0.36 | 12.6% |
| 2024-06-30 | 0.05 | 0.10 | -0.05Net Cash | 0.36 | 12.9% |
| 2024-03-31 | 0.05 | 0.10 | -0.05Net Cash | 0.37 | 12.9% |
| 2023-12-31 | 0.05 | 0.10 | -0.05Net Cash | 0.38 | 12.9% |
| 2023-09-30 | 0.05 | 0.13 | -0.08Net Cash | 0.41 | 12.3% |
| 2023-06-30 | 0.05 | 0.17 | -0.12Net Cash | 0.45 | 11.6% |
| 2023-03-31 | 0.05 | 0.24 | -0.19Net Cash | 0.54 | 9.5% |
| 2022-12-31 | 0.05 | 0.33 | -0.28Net Cash | 0.61 | 8.6% |
| 2022-09-30 | 0.05 | 0.49 | -0.43Net Cash | 0.76 | 6.8% |
| 2022-06-30 | 0.68 | 0.13 | 0.55 | 0.36 | 187.9% |
| 2022-03-31 | 0.67 | 0.15 | 0.53 | 0.36 | 189.4% |
| 2021-12-31 | 0.67 | 0.17 | 0.50 | 0.37 | 178.6% |
| 2021-09-30 | 0.67 | 0.22 | 0.46 | 0.40 | 166.5% |
| 2021-06-30 | 0.67 | 0.26 | 0.40 | 0.43 | 155.7% |
| 2021-03-31 | 0.67 | 0.21 | 0.46 | 0.38 | 179.2% |
| 2020-12-31 | 0.68 | 0.29 | 0.38 | 0.47 | 144.2% |
| 2020-09-30 | 0.67 | 0.36 | 0.31 | 0.51 | 130.6% |
| 2020-06-30 | 0.66 | 0.44 | 0.22 | 0.56 | 116.6% |
| 2020-03-31 | 0.66 | 0.49 | 0.17 | 0.61 | 108.2% |
| 2019-12-31 | 0.51 | 0.28 | 0.23 | 0.41 | 124.9% |
| 2019-09-30 | 0.50 | 0.32 | 0.18 | 0.45 | 111.4% |
| 2019-06-30 | 0.49 | 0.40 | 0.10 | 0.49 | 99.8% |
| 2019-03-31 | 0.49 | 0.43 | 0.06 | 0.53 | 93.2% |
| 2018-12-31 | 0.45 | 0.51 | -0.05Net Cash | 0.56 | 81.1% |
| 2018-09-30 | 0.22 | 0.30 | -0.08Net Cash | 0.37 | 60.5% |
| 2018-06-30 | 0.22 | 0.35 | -0.13Net Cash | 0.42 | 53.2% |
| 2018-03-31 | 0.22 | 0.42 | -0.19Net Cash | 0.48 | 46.7% |
| 2017-12-31 | 0.22 | 0.35 | -0.12Net Cash | 0.44 | 50.7% |
| 2017-09-30 | 0.22 | 0.34 | -0.11Net Cash | 0.49 | 46.0% |
| 2017-06-30 | 0.22 | 0.36 | -0.14Net Cash | 0.54 | 41.0% |
| 2017-03-31 | 0.22 | 0.39 | -0.17Net Cash | 0.59 | 37.9% |
| 2016-12-31 | 0.22 | 0.50 | -0.28Net Cash | 0.64 | 34.8% |
| 2016-09-30 | 0.00 | 0.23 | -0.23Net Cash | 0.36 | 0.0% |
| 2016-06-30 | 0.00 | 0.25 | -0.25Net Cash | 0.37 | 0.0% |
| 2016-03-31 | 0.00 | 0.18 | -0.18Net Cash | 0.29 | 0.0% |
| 2015-12-31 | 0.00 | 0.17 | -0.17Net Cash | 0.30 | 0.0% |
| 2015-09-30 | 0.00 | 0.20 | -0.20Net Cash | 0.26 | 0.0% |
| 2015-06-30 | 0.00 | 0.21 | -0.21Net Cash | 0.29 | 0.0% |
| 2015-03-31 | 0.00 | 0.24 | -0.24Net Cash | 0.32 | 0.0% |
| 2014-12-31 | 0.00 | 0.31 | -0.31Net Cash | 0.34 | 0.0% |
| 2014-09-30 | 0.00 | 0.35 | -0.35Net Cash | 0.38 | 0.0% |
| 2014-06-30 | 0.00 | 0.39 | -0.39Net Cash | 0.43 | 0.0% |
| 2014-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.03 | 0.0% |
| 2013-12-31 | 0.00 | 0.00 | 0.00 | 0.03 | 0.0% |
| 2013-09-30 | 0.00 | 0.00 | 0.00 | 0.02 | 0.0% |
| 2013-06-30 | 0.00 | 0.00 | 0.00 | 0.02 | 0.0% |
| 2013-03-31 | 0.00 | 0.00 | 0.00 | 0.02 | 0.0% |
| 2012-12-31 | 0.00 | 0.00 | 0.00 | 0.02 | 0.0% |